Cargando…
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
HER2/neu is an immunogenic protein inducing both humoral and cell-mediated immune responses. The antigen-specific cytotoxic T lymphocytes (CTLs) are the main effector immune cells in the anti-tumor immunity. To induce an effective CTL specific response against P5+435 single peptide derived from rat...
Autores principales: | Naghibi, Laleh, Yazdani, Mona, Momtazi-Borojeni, Amir Abbas, Razazan, Atefeh, Shariat, Sheida, Mansourian, Mercedeh, Arab, Atefeh, Barati, Nastaran, Arabsalmani, Mahdieh, Abbasi, Azam, Saberi, Zahra, Badiee, Ali, Jalali, Seyed Amir, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728212/ https://www.ncbi.nlm.nih.gov/pubmed/33301467 http://dx.doi.org/10.1371/journal.pone.0243550 |
Ejemplares similares
-
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
por: Razazan, Atefeh, et al.
Publicado: (2017) -
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015) -
Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice
por: Razazan, Atefeh, et al.
Publicado: (2019) -
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019) -
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023)